Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system

被引:435
作者
LaPorte, Sherry L. [1 ]
Juo, Z. Sean [1 ]
Vaclavikova, Jana [1 ]
Colf, Leremy A. [1 ]
Qi, Xiulan [2 ,3 ,4 ]
Heller, Nicola M. [2 ,3 ,4 ]
Keegan, Achsah D. [2 ,3 ,4 ]
Garcia, K. Christopher [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA
[3] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA
关键词
D O I
10.1016/j.cell.2007.12.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-4 and Interleukin-13 are cytokines critical to the development of T cell-mediated humoral immune responses, which are associated with allergy and asthma, and exert their actions through three different combinations of shared receptors. Here we present the crystal structures of the complete set of type I (IL-4R alpha/gamma(c)/IL-4) and type II (IL-4R alpha/IL-13R alpha 1/ IL-4, IL-4R alpha/IL-13R alpha 1/IL-13) ternary signaling complexes. The type I complex reveals a structural basis for gamma(c)'s ability to recognize six different gamma(c)-cytokines. The two type II complexes utilize an unusual top-mounted Ig-like domain on IL-13R alpha 1 for a novel mode of cytokine engagement that contributes to a reversal in the IL-4 versus IL-13 ternary complex assembly sequences, which are mediated through substantially different recognition chemistries. We also show that the type II receptor heterodimer signals with different potencies in response to IL-4 versus IL-13 and suggest that the extracellular cytokine-receptor interactions are modulating intracellular membrane-proximal signaling events.
引用
收藏
页码:259 / 272
页数:14
相关论文
共 55 条
[1]   cDNA cloning and characterization of the human interleukin 13 receptor alpha chain [J].
Aman, MJ ;
Tayebi, N ;
Obiri, NI ;
Puri, RK ;
Modi, WS ;
Leonard, WJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29265-29270
[2]   Kinetic analysis of the interleukin-13 receptor complex [J].
Andrews, AL ;
Holloway, JW ;
Puddicombe, SM ;
Holgate, ST ;
Davies, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (48) :46073-46078
[3]   IL-4 receptor α is an important modulator of IL-4 and IL-13 receptor binding:: Implications for the development of therapeutic targets [J].
Andrews, Allison-Lynn ;
Holloway, John W. ;
Holgate, Stephen T. ;
Davies, Donna E. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (12) :7456-7461
[4]   Characterization of the interaction between interleukin-13 and interleukin-13 receptors [J].
Arima, K ;
Sato, K ;
Tanaka, G ;
Kanaji, S ;
Terada, T ;
Honjo, E ;
Kuroki, R ;
Matsuo, Y ;
Izuhara, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (26) :24915-24922
[5]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[6]   Cytokine modulators as novel therapies for asthma [J].
Barnes, PJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :81-98
[8]  
BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582
[9]   Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130 [J].
Boulanger, MJ ;
Bankovich, AJ ;
Kortemme, T ;
Baker, D ;
Garcia, KC .
MOLECULAR CELL, 2003, 12 (03) :577-589
[10]   Molecular phylogeny within type I cytokines and their cognate receptors [J].
Boulay, JL ;
O'Shea, JJ ;
Paul, WE .
IMMUNITY, 2003, 19 (02) :159-163